Persistent URL of this record https://hdl.handle.net/1887/114401
Documents
-
- Download
- 10.1016-j.vaccine.2017.01.055
- Not Applicable (or Unknown)
-
open access
In Collections
This item can be found in the following collections:
Safety and immunogenicity of the novel H4:IC31 tuberculosis vaccine candidate in BCG-vaccinated adults: Two phase I dose escalation trials
- All authors
- Norrby, M.; Vesikari, T.; Lindqvist, L.; Maeurer, M.; Ahmed, R.; Mandavifar, S.; Bennett, S.; McClain, J.B.; Shepherd, B.M.; Li, D.; Hokey, D.A.; Kromann, I.; Hoff, S.T.; Andersen, P.; Visser, A.W. de; Joosten, S.A.; Ottenhoff, T.H.M.; Andersson, J.; Brighenti, S.
- Date
- 2017-03-14
- Journal
- Vaccine
- Volume
- 35
- Issue
- 12
- Pages
- 1652 - 1661